GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Are GLP-1 supplements 'nature's Ozempic'? Doctors evaluate weight loss claims
GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help people lose weight and are safe.
GLP-1 Tablets Set to Transform Weight-Loss Procedures
The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the marketplace. For those reluctant to inject themselves, more convenient oral solutions may be on the horizon soon.
The best biotech plays outside the GLP-1 weight-loss market
BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best biotech plays outside of the GLP-1 weight-loss space. The sky-high demand for GLP-1 weight-loss drugs has led the biotech sector to reach new heights over the last year,
GLP-1 hybrid drug being tested as weight-loss aid
The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed pounds.
Noom to offer compounded GLP-1 drug to rival pricey branded weight loss meds
Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers. | Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers.
Trainer explains importance of weight lifting while taking weight loss drugs
Weight loss medications are on the rise and Planet Fitness is stressing the importance of maintaining your physical strength and fitness throughout the process.
Weight-loss drugs and children: What doctors say about the safety, effectiveness of the medications
Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being tested on children as young as six years old.
2 Weight Loss Drug Stocks Worth Stashing Away for Years
As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to the chin. Undoubtedly, several investment themes, including generative AI and GLP-1 (weight-loss) drugs,
Becker's Hospital Review2d
GLP-1 weight loss pills are in the works: What to know
GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions ...
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
ConsumerAffairs29m
Weight loss pills vs. injections: Which is right for you?
Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...
What Experts Think About Lemme's New GLP-1 Supplement
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
Do ‘Natural GLP-1 Supplements’ Actually Work As Well As Ozempic? Here’s What Experts Think.
The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.